Fundraising Fox海普瑞
1 known investors
Find your way into 海普瑞
Sign up to see every warm intro you have to 海普瑞
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 海普瑞 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Resverlogix is a late-stage clinical biotechnology company developing epigenetic therapeutics for patients with chronic illnesses and high unmet medical need. It also offers value-based health solutions to stakeholders such as payer groups.
Founders & leadership
DM
Donald McCaffrey
NW
Norman Wong
Investors · 1
Frequently asked questions
- What does 海普瑞 do?
- Resverlogix is a late-stage clinical biotechnology company developing epigenetic therapeutics for patients with chronic illnesses and high unmet medical need. It also offers value-based health solutions to stakeholders such as payer groups.
- Who founded 海普瑞?
- 海普瑞 was founded by Donald McCaffrey, Norman Wong.
- Who are 海普瑞's investors?
- 海普瑞's investors include EFung Capital.